東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Epidemiological associations of meta...

Ahmed-Saucedo, Rehana Leila.

FindBook

Google Book

Amazon

博客來

Epidemiological associations of metabolic factors with cancer risk and cancer late effects.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Epidemiological associations of metabolic factors with cancer risk and cancer late effects./
作者:	Ahmed-Saucedo, Rehana Leila.
面頁冊數:	173 p.
附註:	Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0206.
Contained By:	Dissertation Abstracts International67-01B.
標題:	Health Sciences, Public Health. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3200570
ISBN:	9780542478673

Epidemiological associations of metabolic factors with cancer risk and cancer late effects.
Ahmed-Saucedo, Rehana Leila.

Epidemiological associations of metabolic factors with cancer risk and cancer late effects. - 173 p.

Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0206.

Thesis (Ph.D.)--University of Minnesota, 2006.

There is interest in developing our knowledge of modifiable cancer risk factors. The three studies in this dissertation investigate the role of metabolic factors at two points along the cancer control continuum: etiology and treatment late-effects.

ISBN: 9780542478673Subjects--Topical Terms:

1017659
Health Sciences, Public Health.

Epidemiological associations of metabolic factors with cancer risk and cancer late effects.
LDR:03400nmm 2200325 4500 001 1825083
005 20061201092001.5
008 130610s2006 eng d
020 $a 9780542478673
035 $a (UnM)AAI3200570
035 $a AAI3200570
040 $a UnM $c UnM
100 1 $a Ahmed-Saucedo, Rehana Leila. $3 1914107
245 1 0 $a Epidemiological associations of metabolic factors with cancer risk and cancer late effects.
300 $a 173 p.
500 $a Source: Dissertation Abstracts International, Volume: 67-01, Section: B, page: 0206.
500 $a Advisers: Kathryn H. Schmitz; Aaron R. Folsom.
502 $a Thesis (Ph.D.)--University of Minnesota, 2006.
520 $a There is interest in developing our knowledge of modifiable cancer risk factors. The three studies in this dissertation investigate the role of metabolic factors at two points along the cancer control continuum: etiology and treatment late-effects.
520 $a The first two studies examined questions of cancer etiology. The first examined the hypotheses that the metabolic syndrome and physical inactivity are associated positively with incident colorectal cancer in a large prospective cohort of men and women. There was a dose-response association between colorectal cancer and the number of metabolic syndrome components present at baseline (Ptrend: 0.05) after multivariate adjustment. Metabolic syndrome (≥ 3 vs. 0 components) was associated positively with age- and gender-adjusted colorectal cancer (RR: 1.71 [95% CI: 1.1, 2.7]); this association was attenuated after multivariate adjustment (RR: 1.49 [0.9, 2.4]). The multivariate-adjusted association was strong in men (RR: 2.20 [1.1, 4.3]) and absent in women (RR: 1.01 [0.5, 2.0]). There was no association between physical activity and colorectal cancer (Sports Index Q4 vs. Q1 RR: 0.82 [0.5,1.2]).
520 $a The second study examined the hypothesis that a randomized 39-week strength-training intervention in 57 women would increase insulin-like growth factor binding-protein (IGFBP)-2 levels in the treatment versus control group. Further analyses examined cross-sectional and longitudinal associations between body fat, insulin, and IGF-axis proteins (IGF-I and IGFBPs-1, -2, and -3). No intervention effect was observed for IGFBP-2 levels over 15 or 39 weeks (2-sided regression: p = 0.97 and p = 0.91, respectively). Body fat and insulin were inversely associated with IGFBP-1 and -2, but were not associated with IGF-I and IGFBP-3, at baseline and over 39 weeks.
520 $a The third project examined cancer late-effects and examined the hypotheses that a randomized twice-weekly strength training intervention in 78 recent breast cancer survivors would not increase the incidence of lymphedema or its symptoms. Incidence of clinically diagnosed lymphedema between baseline and six-months was 6.4% and 5.9% in the treatment and control groups, respectively (p = 0.54). Self-report symptoms did not vary between the two groups at six months (p = 0.24). No participant experienced a change in arm circumference measures after the intervention.
590 $a School code: 0130.
650 4 $a Health Sciences, Public Health. $3 1017659
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0573
690 $a 0992
710 2 0 $a University of Minnesota. $3 676231
773 0 $t Dissertation Abstracts International $g 67-01B.
790 1 0 $a Schmitz, Kathryn H., $e advisor
790 1 0 $a Folsom, Aaron R., $e advisor
790 $a 0130
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3200570